211 related articles for article (PubMed ID: 15238137)
1. Toward more effective antifungal therapy: the prospects of combination therapy.
Kontoyiannis DP; Lewis RE
Br J Haematol; 2004 Jul; 126(2):165-75. PubMed ID: 15238137
[TBL] [Abstract][Full Text] [Related]
2. Decision making in antifungal monotherapy versus combination therapy.
Lewis RE
Pharmacotherapy; 2006 Jun; 26(6 Pt 2):61S-67S. PubMed ID: 16716124
[TBL] [Abstract][Full Text] [Related]
3. The rationale of combination antifungal therapy in severely immunocompromised patients: empiricism versus evidence-based medicine.
Chamilos G; Kontoyiannis DP
Curr Opin Infect Dis; 2006 Aug; 19(4):380-5. PubMed ID: 16804387
[TBL] [Abstract][Full Text] [Related]
4. Combination antifungals: an update.
Segal BH; Steinbach WJ
Expert Rev Anti Infect Ther; 2007 Oct; 5(5):883-92. PubMed ID: 17914921
[TBL] [Abstract][Full Text] [Related]
5. Update on antifungal treatment of invasive Candida and Aspergillus infections.
Maschmeyer G; Ruhnke M
Mycoses; 2004 Aug; 47(7):263-76. PubMed ID: 15310328
[TBL] [Abstract][Full Text] [Related]
6. Pediatric antifungal therapy. Part I: focus on febrile neutropenia, invasive aspergillosis, combination antifungal therapy and invasive candidiasis in immunocompromised pediatric patients.
Allen U; Bow E; Doyle J; Richardson S; Robinson J; Rotstein C; Davies D; Hui C; Le Saux N; Laverdiere M; Read S
Minerva Pediatr; 2010 Feb; 62(1):57-69. PubMed ID: 20212399
[TBL] [Abstract][Full Text] [Related]
7. Combination antifungal therapy: a critical review of the evidence.
Ostrosky-Zeichner L
Clin Microbiol Infect; 2008 May; 14 Suppl 4():65-70. PubMed ID: 18430131
[TBL] [Abstract][Full Text] [Related]
8. Fungal infections in the immunocompromised host.
Hawkins C; Armstrong D
Clin Haematol; 1984 Oct; 13(3):599-630. PubMed ID: 6388935
[TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamic implications for use of antifungal agents.
Lewis RE
Curr Opin Pharmacol; 2007 Oct; 7(5):491-7. PubMed ID: 17616480
[TBL] [Abstract][Full Text] [Related]
10. Improved outcomes associated with advances in therapy for invasive fungal infections in immunocompromised hosts.
Metcalf SC; Dockrell DH
J Infect; 2007 Oct; 55(4):287-99. PubMed ID: 17697716
[TBL] [Abstract][Full Text] [Related]
11. Fungicidal versus Fungistatic: what's in a word?
Lewis JS; Graybill JR
Expert Opin Pharmacother; 2008 Apr; 9(6):927-35. PubMed ID: 18377336
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in antifungal chemotherapy.
Petrikkos G; Skiada A
Int J Antimicrob Agents; 2007 Aug; 30(2):108-17. PubMed ID: 17524625
[TBL] [Abstract][Full Text] [Related]
13. Combinatorial strategies for combating invasive fungal infections.
Spitzer M; Robbins N; Wright GD
Virulence; 2017 Feb; 8(2):169-185. PubMed ID: 27268286
[TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy of new antifungal agents.
Kauffman CA
Curr Opin Microbiol; 2006 Oct; 9(5):483-8. PubMed ID: 16904366
[TBL] [Abstract][Full Text] [Related]
15. Combination therapeutic approaches for the management of invasive aspergillosis in organ transplant recipients.
Singh N; Pursell KJ
Mycoses; 2008 Mar; 51(2):99-108. PubMed ID: 18254745
[TBL] [Abstract][Full Text] [Related]
16. Clinical practice: combination antifungal therapy for mold infections: much ado about nothing?
Vazquez JA
Clin Infect Dis; 2008 Jun; 46(12):1889-901. PubMed ID: 18466092
[TBL] [Abstract][Full Text] [Related]
17. The place for itraconazole in treatment.
Maertens J; Boogaerts M
J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i33-i38. PubMed ID: 16120632
[TBL] [Abstract][Full Text] [Related]
18. [Drug resistance in the treatment of invasive fungal infections].
Nordøy I; Gaustad P
Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2607-11. PubMed ID: 19023376
[TBL] [Abstract][Full Text] [Related]
19. Antifungal pharmacokinetics and pharmacodynamics: bridging from the bench to bedside.
Hope WW; Drusano GL
Clin Microbiol Infect; 2009 Jul; 15(7):602-12. PubMed ID: 19673971
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy for invasive mycoses: evaluation of past clinical trial designs.
Sobel JD
Clin Infect Dis; 2004 Oct; 39 Suppl 4():S224-7. PubMed ID: 15546122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
